Mdxhealth Sa ADR MDXH

$0.57 -0.01 (-0.90%)

Valuation

Market cap
28,520,000
Revenue TTM
$107,880,000
Net income TTM
$-33,520,000
PE ratio
0.00
Forward PE
—
Profit margin
-31.07%
Debt to equity
-3.17

Trading

Volume
79,300
Avg volume
7,200,972
Day's range
$0.56 – $0.60
Shares out
49,497,000
Stochastic %K
43%
Beta
1.68
Analysts
Strong Sell
Price target
$2.00

Price

Company profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having c...

Show more

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
866 259 5644
Website
https://mdxhealth.com
Address
CAP Business Center, Rue d’Abhooz 31 Zone Industrielle des Hauts-Sarts, Herstal, Belgium

Latest news

Stocktwits

drweinerdog1 Sep 30, 9:33 PM
$MDXH fill me up , 20k at .53
0 replies
Struin Sep 28, 3:30 PM
$MDXH sorry 0,55 now
0 replies
Struin Sep 25, 4:25 PM
$MDXH $2 companny now , what a price 0,5681!!!
0 replies
ElonRMusk Sep 21, 4:24 PM
$MDXH the S&P is having an electric day, and this dogshit is down 5%. WAKE UP MDXHEALTH!!
0 replies
ElonRMusk Sep 18, 7:31 PM
$MDXH market is punishing the company for remaining silent for such a long period. Market rewards companies with good communication and to keep investors interested. Wake up Mdxhealth investor relations!
0 replies
n9zro Sep 16, 7:34 PM
$MDXH I now hold 20,000 shares..I m done buying til this shows some much greater volume...
0 replies
n9zro Sep 15, 7:02 PM
$MDXH I now have 17 000 shares..will continue to BUY
0 replies
ElonRMusk Sep 15, 1:31 PM
$MDXH little birdie told me the company has confidence they will organically grow the SP past the $1.00 mark prior to the Dec 28th deadline, and a reverse split isnt in the cards (for now). Makes sense, since the companies recently bought in the financing wouldnt have participated if they thought that was a risk in the near term.
0 replies